Premiere Cooperative Group in Adult Lymphoma Research (GELA) Chooses ... - CNBC San Francisco Luxury News The combination of REVLIMID (lenalidomide) and rituximab, also referred to as the R-squared (or R(2)) regimen pioneered by Nathan Fowler, MD and colleagues at the MD Anderson Cancer Center, Houston TX, will be investigated in a study of up to 1000 ... Final Phase II Data Evaluating REVLIMID(R) and Rituximab in Patients with ... |
